Compare CEPU & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CEPU | PBH |
|---|---|---|
| Founded | 1989 | 1996 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | 2017 | 2004 |
| Metric | CEPU | PBH |
|---|---|---|
| Price | $14.33 | $49.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $17.50 | ★ $75.33 |
| AVG Volume (30 Days) | 250.3K | ★ 642.2K |
| Earning Date | 05-15-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.91 |
| Revenue | N/A | ★ $975,777,000.00 |
| Revenue This Year | $10.11 | N/A |
| Revenue Next Year | N/A | $4.31 |
| P/E Ratio | ★ $12.24 | $12.95 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $7.43 | $42.62 |
| 52 Week High | $18.50 | $77.45 |
| Indicator | CEPU | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 43.38 | 54.06 |
| Support Level | $13.87 | $44.86 |
| Resistance Level | $16.45 | $49.79 |
| Average True Range (ATR) | 0.57 | 1.52 |
| MACD | -0.04 | 0.24 |
| Stochastic Oscillator | 20.42 | 59.78 |
Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.